PFE

#99
Pfizer, Inc. Common Stock
26.1 0 USD
+0.15%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
26.01
26.13
Range Annuel
23.06
28.75
Changement quotidien
+0.15%
Changement Mensuel
-1.10%
Evolution sur 6 mois
+1.32%
Changement Annuel
+11.06%
Clôture Précédente
26.0 6
Open
26.0 3
Low
26.0 1
High
26.1 3
Volume
2 163
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 148.76 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
21.2
ratio cours/chiffre d'affaires
2.51
Dividende par action
—
Rendement du dividende (%)
9.29

Pfizer, Inc. Common Stock

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

Nouvelles